M&A Transaction Database
Oncology M&A Transactions
Mergers and acquisitions in the Oncology subsector.
Never miss a transaction
Get instant notifications when new M&A transactions matching "Oncology" are published.
Filters
4 shown
Vithas is in advanced talks to acquire GenesisCare's Spanish oncology business for €40-50 million, significantly expanding its cancer treatment services.
Ipsen secures Kartos Therapeutics' navtemadlin in a deal up to $1.75B, enhancing its hemato-oncology pipeline with a promising myelofibrosis treatment.
Ipsen secures navtemadlin, a novel myelofibrosis therapy, in a deal valued up to $1.3 billion, targeting unmet needs in rare blood cancers.
Thalia Therapeutics
Thalia Therapeutics Acquires Sanmirna, Raises €3.1 MillionUK biotech Thalia Therapeutics secures €3.1 million and acquires Sanmirna Therapeutics, enhancing its RNA-based oncology and cardiovascular drug development.
Never Miss a Deal
Get weekly investment intelligence. Free forever.
You reached the end (4 deals).